Navigation Links
Maastricht University Medical Centre Advances Cranial Implant Technology with PEEK-OPTIMA
Date:6/2/2010

Maastricht University Medical Centre (MUMC+) has developed a novel cranio-maxillofacial implant technology that uses an advanced polymer biomaterial, PEEK-OPTIMA®, from Invibio Biomaterial Solutions. The polymer derived Patient Specific Implant (PSI) technology extends the range of patient/surgeon benefits beyond those of medical-grade titanium, the traditional biomaterial used for cranio-maxillofacial PSIs.

(PRWEB) June 2, 2010 -- Maastricht University Medical Centre (MUMC+) has developed a novel cranio-maxillofacial implant technology that uses an advanced polymer biomaterial, PEEK-OPTIMA®, from Invibio Biomaterial Solutions, to extend benefits to patients with severe malformation and defects of the skull and facial region. Patient-specific cranial implants are most commonly used to treat skull defects resulting from trauma, tumors and aneurysms.

The PEEK-OPTIMA® derived Patient Specific Implant (PSI) technology extends the range of patient/surgeon benefits beyond those of medical-grade titanium, the traditional biomaterial used for cranio-maxillofacial PSIs. The MUMC+ process uses CAD software to design the PSI to the individual cranio-maxillofacial contours of the patient. The customized implants are produced on-site, using a high speed milling fabrication process.

According to Maikel Beerens (B.Sc. in Medical Engineering), who initially designed and now markets IDEE’s (Instrument Development Engineering & Evaluation) patient specific implants (PSI), PEEK-OPTIMA’s material characteristics and performance properties provide real and valuable surgeon/patient benefits that include:

 
  • Ideal biological properties very comparable to bone;
  • No stress shielding;
  • No conductibility of temperature;
  • Separation of PEEK from surrounding bone, which ensures the initial position of the implant
  • Proven biocompatibility and biostability,
  • Natural radiolucency and compatibility with medical imaging to monitor site healing

“The patient’s own removed bone segments are always the first choice for implantation. However, unfortunately only a few of those re-implantations succeed, leaving the patient with a defect. To reconstruct this defect in the best way possible the surgeon uses a patient specific implant.

Although the use of PEEK is relatively new in the case of cranial implants, Invibio’s PEEK-OPTIMA® is proven with over 10 years of history in a wide variety of different regulatory approved devices. Their verified biocompatibility and biostability is crucial for surgeons when choosing materials”, commented Peter Kessler (chair professor, Department of Cranio-Maxillofacial Surgery, MUMC+).

The novel cranio-maxillofacial implant technology was co-developed by Maastricht University Medical Centre’s engineering department IDEE (Instrument Development Engineering & Evaluation), the Department of Cranio-Maxillofacial Surgery and Maastricht Instruments (MI).

About Invibio:
Invibio® is a global leader providing high performance biomaterials, advanced technical research and consultative solutions to medical device manufacturers across a wide range of markets. The company provides medical device manufacturers with PEEK-OPTIMA® polymer and compounds, MOTIS™ polymer, ENDOLIGN® composite and PEEK-CLASSIX™ polymer for the development of long- and short-term implantable medical devices.

For more information, please contact Invibio at: 866 468 4246 or +484 342 6004 (U.S.), +44 (0) 1253 898000 (U.K.), +852 2366 4448 (Asia Pacific) or online at www.invibio.com.

About IDEE:
IDEE (Instrument Development Engineering & Evaluation) is the engineering department of Maastricht University (UM). It provides services to the Faculty of Health, Medicine & Life Sciences (FHML) as well as the university hospital Maastricht (azM) together named MUMC+. IDEE develops innovative and unique medical devices to support academic, medical and industrial R&D focused on Life Sciences.

About Maastricht Instruments:
Maastricht Instruments BV (MI) is a high-tech solution provider within the medical field and life sciences as well as industrial related R&D. Located within the premises of the MUMC+ and working very closely with IDEE and the local medical researchers, MI has access to in-depth medical knowledge and experience. Based upon the medical know-how, combined with excellent competences of mechanical, electronic and software development, MI is able to realize creative proof of concept equipment & services and innovative “first of a kind” prototypes. Typical customers are researchers from universities, (academic) hospitals, medical centers, care institutes and industrial R&D institutes worldwide.
For more information, please contact MI at: Tel +31 (0) 43 3881371 or online at www.maastrichtinstruments.com, in the Patient Specific Implants section.

About the Maastricht University Medical Centre (MUMC+):
The Department of Cranio-Maxillofacial Surgery of the Maastricht University Medical Centre is specialized in cranio-maxillofacial reconstructions. The range of reconstructive procedures comprises also the reconstruction of large skull bone defects of various origins. Customized implants of various materials can be applied. The experience and close cooperation with the Department of Neurosurgery renders excellent functional and aesthetic results. The cooperation with IDEE guarantees safety, reliability and the of use state-of-the-art technologies. For more information visit MUMC+ at www.azm.nl.

###

Read the full story at http://www.prweb.com/releases/2010/06/prweb4074614.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. University of Minnesota, Mayo Clinic sign research pact with Karolinska
2. New research at the University of Leicester links shoplifting to your personality
3. University of Colorado Hospital Moving Forward with $400 Million Expansion
4. University Hospitals Neurological Institute earns Neuroscience Center of Excellence designation
5. Center for the Study of Aging established at University of Denver
6. University of Washington launches project to discover fundamentals of early learning
7. University of Washington Institute for Learning & Brain Sciences Launches Developing Mind Project
8. Water Enabled Technologies of Utah Signs MOU with Clemson University, South Carolina, for Water Desalination
9. Chicago Trial Attorney Inducted as Loyola University Chicago School of Law's First Cooney & Conway Chair in Advocacy
10. Life sciences research grants awarded through Inova Health System and George Mason University
11. FightSMA Awards $250,000 Grant to Gene Researcher at The Ohio State University
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Maastricht University Medical Centre Advances Cranial Implant Technology with PEEK-OPTIMA 
(Date:4/26/2017)... ... 26, 2017 , ... Miami native and local periodontist Dr. John Paul ... never imagined back in 1991 that this journey would have taken me into so ... 25 years, Dr. Gallardo has pioneered implant dentistry innovation, evolving into an internationally recognized ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... agile ecosystem and domain expertise for sponsors and CROs to speed clinical ... supply management (RTSM) software platform. Bioclinica AGILE RTSM provides seamless ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... attempts to compare student test score performance for the 2015-16 school year across ... state’s voucher programs. Though it highlights important patterns in student test score performance, ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical ... partners to help with process innovation in drug formulation and manufacturing. CoreRx ... with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
(Date:4/18/2017)...  Astute Medical, Inc., developer of biomarkers for better ... at the 2017 National Kidney Foundation (NKF) Spring ... April 22. Physicians will present data on two biomarkers, ... for acute kidney injury (AKI) during the management of ... Elevated levels of TIMP-2 and IGFBP-7 have been ...
Breaking Medicine Technology: